. . "Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis"@ast . . . . . . "\u043D\u0430\u0443\u0447\u043D\u0438 \u0447\u043B\u0430\u043D\u0430\u043A"@sr . . "Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis"@en . "Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis"@ast . . . . . . . . "Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis"@en . . "2791500" . . . . . . . . "19782104" . . "artigo cient\u00EDfico"@pt . . . . . . . . . . . . "2009-09-24T00:00:00Z"^^ . "videnskabelig artikel"@da . . . "10.1016/J.BBR.2009.09.028" . . "Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis"@ast . . . . . . "vedeck\u00FD \u010Dl\u00E1nok"@sk . . . . . . "Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis"@nl . . . . . . . . . . . . . . . . . . . . "Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis"@nl . . . . . . . . "wissenschaftlicher Artikel"@de . . . . . . . . . . "vetenskaplig artikel"@sv . . . . . . "scientific article published on 24 September 2009"@en . . . . . . . . . . . . . . . . . . . . . . "bilimsel makale"@tr . "article cient\u00EDfic"@ca . "Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis"@nl . . . . . "Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis"@en . . "2" . . . "26838951" . . "v\u011Bdeck\u00FD \u010Dl\u00E1nek"@cs . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0443 \u0432\u0435\u0440\u0435\u0441\u043D\u0456 2009"@uk . "articolo scientifico"@it . . . "Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis"@en . . "Cheryl A Frye" . . "206" . "Alicia A Walf" . "article scientifique"@fr . . . "wetenschappelijk artikel"@nl . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en 2009"@ast . "286-292" . . . "\u0645\u0642\u0627\u0644\u0629 \u0639\u0644\u0645\u064A\u0629 \u0646\u0634\u0631\u062A \u0641\u064A 24 \u0633\u0628\u062A\u0645\u0628\u0631 2009"@ar . .